Abstract
This review highlights the many roles mass spectrometry plays in the discovery and development of new therapeutics by both the pharmaceutical and the biotechnology industries. Innovations in mass spectrometer source design, improvements to mass accuracy, and implementation of computer-controlled automation have accelerated the purification and characterization of compounds derived from combinatorial libraries, as well as the throughput of pharmacokinetics studies. The use of accelerator mass spectrometry, chemical reaction interface-mass spectrometry and continuous flow-isotope ratio mass spectrometry are promising alternatives for conducting mass balance studies in man. To meet the technical challenges of proteomics, discovery groups in biotechnology companies have led the way to development of instruments with greater sensitivity and mass accuracy (e.g., MALDI-TOF, ESI-Q-TOF, Ion Trap), the miniaturization of separation techniques and ion sources (e.g., capillary HPLC and nanospray), and the utilization of bioinformatics. Affinity-based methods coupled to mass spectrometry are allowing rapid and selective identification of both synthetic and biological molecules. With decreasing instrument cost and size and increasing reliability, mass spectrometers are penetrating both the manufacturing and the quality control arenas. The next generation of technologies to simplify the investigation of the complex fate of novel pharmaceutical entities in vitro and in vivo will be chip-based approaches coupled with mass spectrometry.
Similar content being viewed by others
REFERENCES
H. Kubinyi. Strategies and recent technologies in drug discovery. Pharmazie. 50:647-662 (1995).
C. M. Whitehouse, R. N. Dreyer, M. Yamashita, and J. B. Fenn. Electrospray interface for liquid chromatographs and mass spectrometers. Anal. Chem. 57:675-679 (1985).
M. Karas and F. Hillenkamp. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 60:2299-2301 (1988).
S. Pleasance, S. W. Ayer, M. V. Laycock, and P. Thibault. Ion-spray mass spectrometry of marine toxins. III. Analysis of paralytic shellfish poisoning toxins by flow-injection analysis, liquid chromatography/mass spectrometry and capillary electrophoresis/mass spectrometry. Rapid Commun. Mass Spectrom. 6:14-24 (1992).
T. Wang, L. Zeng, T. Strader, L. Burton, and D. B. Kassel. A New UltraFast FIA-MS Method for Microtiter Plate Analysis Using an Eight Probe Injection System. Proceedings of the 46th ASMS Conference on Mass Spectrometry and Allied Topics, Florida, May 31–June 4, 1998, pp. 1034.
L. Zeng and D. B. Kassel. Developments of a fully automated parallel HPLC/mass spectrometry system for the analytical characterization and preparative purification of combinatorial libraries. Anal. Chem. 70:4380-4388 (1998).
V. de Biasi, N. Haskins, A. Organ, R. Bateman, K. Giles, and S. Jarvis. High throughput liquid chromatography/mass spectrometric analyses using a novel multiplexed electrospray interface. Rapid Commun. Mass Spectrom. 13:1165-1168 (1999).
Y. T. Lily, W. Goetzinger, and J. N. Kyranos. UltraFast HPLC/MS for the Identification and Characterization of Combinatorial Library Compounds. Proceedings of the 46th ASMS Conference on Mass Spectrometry and Allied Topics, Orlando, Florida, May 31–June 4, 1998, pp. 1035.
S. Jarvis, D. Little, J. Hoyes, S. Preece, D. Daley, and R. Scammell. Automated Exact Mass Measurements of Combinatorial Libraries by ESI-TOF-MS. Proceedings of the 46th ASMS Conference on Mass Spectrometry and Allied Topics, Orlando, Florida, May 31–June 4, 1998, pp. 1043.
M. C. Ventura, W. P. Farrell, C. M. Aurigemma, and M. J. Greig. Packed column supercritical fluid chromatography/mass spectrometry for high-throughput analysis. Part 2. Anal. Chem. 71:4223-4231 (1999).
T. A. Berger and W. H. Wilson. High-speed screening of combinatorial libraries by gradient packed-column supercritical fluid chromatography. J. Biochem. Biophys. Methods 43:77-85 (2000).
B. H. Hsu, E. Orton, S. Y. Tang, and R. A. Carlton. Application of evaporative light scattering detection to the characterization of combinatorial and parallel synthesis libraries for pharmaceutical drug discovery. J. Chromatogr. B. Biomed. Sci. Appl. 725: 103-12 (1999).
M. Dreux, M. Lafosse, and L. Morin-Allory. The evaporative light scattering detector: A universal instrument for non volatile solutes in LC and SFC. LC · GC Int. 9:148-156 (1996).
J. N. Kyranos and J. C. Hoga. High-throughput characterization of combinatorial libraries. Modern Drug Discovery 2:73-81 (1999).
M. C. Ventura, W. P. Farrell, C. M. Aurigemma, and M. J. Greig. Optimizing quality control of combinatorial libraries with SFC/MS. Proceedings of the 48th ASMS Conference on Mass Spectrometry and Allied Topics, Long Beach, California, June 11–15, 2000, p. 220.
L. Schultz, C. D. Garr, L. M. Cameron, and J. Bukowski. High throughput purification of combinatorial libraries. Bioorg. Med. Chem. Lett. 8:2409-2414 (1998).
P. Bevan, H. Ryder, and I. Shaw. Identifying small-molecule lead compounds: The screening approach to drug discovery. Trends Biotech. 13:115-121 (1995).
Y-H. Chu, Y. M. Dunayevskiy, D. P. Kirby, P. Vouros, and B. L. Karger. Affinity capillary electrophoresis-mass spectrometry for screening combinatorial libraries. J. Am. Chem. Soc. 118:7827-7835 (1996).
L. Yang and C. S. Lee. Micellar electrokinetic chromatography-mass spectrometry. J. Chromatogr. A. 780:207-218 (1997).
Y. V. Lyubarskaya, S. A. Carr, D. Dunnington, W. P. Prichett, S. M. Fisher, E. R. Appelbaum, C. S. Jones, and B. L. Karger. Screening for high-affinity ligands to the SRC SH2 domain using capillary isoelectric focusing-electrospray ionization ion trap mass spectrometry. Anal. Chem. 70:4761-4770 (1998).
Y. Z. Zhao, R. B. van Breemen, D. Nikolic, C. R. Huang, C. P. Woodbury, A. Schilling, and D. L. Venton. Screening solution-phase combinatorial libraries using pulsed ultrafiltration/electrospray mass spectrometry. J. Med. Chem. 40:4006-4012 (1997).
M. A. Kelly, H. Liang, I. I. Sytwu, I. Vlattas, N. L. Lyons, B. R. Bowen, and L. P. Wennogle. Characterization of SH2-ligand interactions via library affinity selection with mass spectrometric detection. Biochemistry 35:11747-11755 (1996).
M. L. Nedved, S. Habibi-Goudarzi, B. Ganem, and J. D. Henion. Characterization of benzodiazepine “combinatorial” chemical libraries by on-line immunoaffinity extraction, coupled column HPLC-ion spray mass spectrometry-tandem mass spectrometry. Anal. Chem. 68:4228-4236 (1996).
S. Kaur, L. McGuire, D. Tang, G. Dollinger, and V. Huebner. Affinity selection and mass spectrometry-based strategies to identify lead compounds in combinatorial libraries. J. Protein Chem. 16:505-511 (1997).
http://www.cetek.com
R. Lipper. An overview of developability considerations in lead selection and optimization. Presented at PhARMA Conference on “Cycle Time Reduction in Pharmaceutical and Analytical Development,” April 1999, Florida.
E. Brewer and J. Henion. Atmospheric pressure ionization LC/MS/MS techniques for drug disposition studies. J. Pharm. Sci. 87:395-402 (1998).
M. Jemal, D. Teitz, Z. Ouyang, and S. Khan. Comparison of plasma sample purification by manual liquid-liquid extraction, automated 96-well liquid-liquid extraction and automated 96-well solid-phase extraction for analysis by high-performance liquid chromatography with tandem mass spectrometry. J. Chromatogr. Biomed. Sci. Appl. 732:501-508 (1999).
H. Simpson, A. Berthemy, D. Buhrman, R. Burton, J. Newton, M. Kealy, D. Wells, and D. Wu. High throughput liquid chromatography/mass spectrometry bioanalysis using 96-well disk solid phase extraction plate for the sample preparation. Rapid Commun. Mass Spectrom. 12:75-82 (1998).
M. Zell, C. Husser, and G. Hopfgartner. Column-switching high-performance liquid chromatography combined with ion-spray tandem mass spectrometry for the simultaneous determination of the platelet inhibitor Ro 44-3888 and its pro-drug and precursor metabolite in plasma. Mass Spectrom. 32:23-32 (1997).
A. Marchese, C. McHugh, J. Kehler, and H. Bi. Determination of Pranlukast and its metabolites in human plasma by LC/MS/MS with PROSPEKT on-line solid-phase extraction. J. Mass Spectrom. 33:1071-1079 (1998).
V. C. Gao, W. C. Luo, Q. Ye, and M. Thoolen. Column switching in high-performance liquid chromatography with tandem mass spectrometric detection for high-throughput preclinical pharmacokinetic studies. J. Chromatogr. A 828:141-148 (1998).
R. A. van der Hoeven, A. J. Hofte, M. Frenay, H. Irth, U. R. Tjaden, J. van der Greef, A. Rudolphi, K. S. Boos, G. Marko Varga, and L. E. Edholm. Liquid chromatography-mass spectrometry with on-line solid-phase extraction by a restricted-access C18 precolumn for direct plasma and urine injection. Chromatogr. 762:193-200 (1997).
C. L. Stevenson, P. F. Augustijns, and R. W. Hendren. Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures. Int. J. Pharm. 177:103-115 (1999).
W. A. Korfmacher, C. A. Palmer, C. Nardo, K. Dunn-Meynell, D. Grotz, K. Cox, C. C. Lin, C. Elicone, C. Liu, and E. Duchoslav. Development of an automated mass spectrometry system for the quantitative analysis of liver microsomal incubation samples: a tool for rapid screening of new compounds for metabolic stability. Rapid Commun. Mass Spectrom. 13:901-907 (1999).
C. Gu, D. Nikolic, J. Lai, X. Xu, and R. B. van Breemen. Assays of ligand-human serum albumin binding using pulsed ultrafiltration and liquid chromatography-mass spectrometry. Comb. Chem. High Throughput Screen 2:353-359 (1999).
E. H. Kerns. Accelerated stability screens for drug optimization. Presented at the First AAPS Frontier Sympoium: From Good Ligands to Good Drugs: Optimizing Pharmaceutical Properties by Accelerated Screening, 1998, Bethesda, MD.
L. W. Frick, K. K. Adkison, K. J. WellsKnecht, P. Woollard, and D. M. Higton. Cassette dosing: rapid in vivo assessment of pharmacokinetics. Pharm. Sci. & Tech. Today 1:12-18 (1998).
T. V. Olah, R. C. King, and C. L. Fernandez-Metzler. Application of LC-MS/MS quantitative analytical methods to drug metabolism studies in drug discovery. Presented at the First AAPS Frontier Symposium: From Good Ligands to Good Drugs: Optimizing Pharmaceutical Properties by Accelerated Screening, 1998, Bethesda, MD.
C. E. Hop, Z. Wang, Q. Chen, and G. Kwei. Plasma-pooling methods to increase throughput for in vivo pharmacokinetic screening. J. Pharm. Sci. 87:901-903 (1998).
B. S. Kuo, T. Van Noord, M. R. Feng, and D. S. Wright. Sample pooling to expedite bioanalysis and pharmacokinetic research. J. Pharm. Biomed. Anal. 16:837-846 (1998).
J. D. Gilbert, T. V. Olah, M. J. Morris, A. Bortnick, and J. Brunner. The use of stable isotope labeling and liquid chromatography-tandem mass spectrometry techniques to simultaneously determine the oral and ophthalmic bioavailability of timolol in dogs. J. Chromatogr. Sci. 36:163-168 (1998).
H. J. Jr. Pieniaszek, M. Mayersohn, M. P. Adams, R. J. Reinhart, and J. S. Barrett. Moricizine bioavailability via simultaneous, dual, stable isotope administration: Bioequivalence implications. J. Clin. Pharmacol. 39:817-825 (1999).
N. Zhang, S. T. Fountain, H. Bi, and D. T. Rossi. Quantification and rapid metabolite identification in drug discovery using API time-of-flight LC/MS. Anal. Chem. 72:800-806 (2000).
F. Beaudry, J. C. Yves Le Blanc, M. Coutu, I. Ramier, J. P. Moreau, and N. K. Brown. Metabolite profiling study of propranolol in rat using LC/MS/MS analysis. Biomed. Chromatogr. 13:363-369 (1999).
H. Z. Bu, M. Poglod, R. G. Micetich, and J. K. Khan. Structure elucidation of three isomeric metabolites of SYN-2836, a novel antifungal agent, in dogs via liquid chromatography/mass spectrometry and liquid chromatography/tandem mass spectrometry methodologies. J. Mass Spectrom. 34:1185-1194 (1999).
X. Yu, D. Cui, and M. R. Davis. Identification of in vitro metabolites of Indinavir by “intelligent automated LC-MS/MS” (INTAMS) utilizing triple quadrupole tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 10:175-183 (1999).
C. L. Fernandez-Metzler, K. G. Owens, T. A. Baillie, and R. C. King. Rapid liquid chromatography with tandem mass spectrometry-based screening procedures for studies on the biotransformation of drug candidates. Drug Metab. Dispos. 27:32-40 (1999).
P. R. Tiller, A. P. Land, I. Jardine, D. M. Murphy, R. Sozio, A. Ayrton, and W. H. Schaefer. Application of liquid chromatography-mass spectrometry(n) analyses to the characterization of novel glyburide metabolites formed in vitro. J. Chromatogr. A 794:15-25 (1998).
G. J. Dear, J. Ayrton, R. Plumb, and I. J. Fraser. The rapid identification of drug metabolites using capillary liquid chromatography coupled to an ion trap mass spectrometer. Rapid Commun. Mass Spectrom. 13:456-463 (1999).
G. Hopfgartner, I. V. Chernushevich, T. Covey, J. B. Plomley, and R. Boner. Exact mass measurement of product ions for the structural elucidation of drug metabolites with a tandem quadrupole orthogonal-acceleration time-of-flight mass spectrometer. J. Am. Soc. Mass Spectrom. 10:1305-1314 (1999).
H. K. Lim, S. Stellingweif, S. Sisenwine, and K. W. Chan. Rapid drug metabolite profiling using fast liquid chromatography, automated multiple-stage mass spectrometry and receptor-binding. J. Chromatogr. A 831:227-241 (1999).
J. S. Vogel, K. W. Turteltaub, R. Finkel, and E. D. Nelson. Accelerator mass spectrometry. Anal. Chem. 67:353A-359A (1995).
S. D. Gilman, S. J. Gee, B. D. Hammock, J. S. Vogel, K. Haack, B. A. Buchholz, S. P. Freeman, R. C. Wester, X. Hui, and H. I. Maibach. Analytical performance of accelerator mass spectrometry and liquid scintillation counting for detection of 14C-labeled atrazine metabolites in human urine. Anal. Chem. 70: 3463-3469 (1998).
J. Barker and R.C. Garner. Biomedical applications of accelerator mass spectrometry isotope measurements at the level of the atom. Rapid Commun. Mass Spectrom. 13:285-293 (1999).
Website for diagram of a small accelerator mass spectrometer. http://ihp-powerl.ethz.ch/ipp/tandem/tandy/Tandy_home.htm/
A. Nakagawa, A. Kitagawa, M. Asami, K. Nakamura, D. A. Schoeller, R. Slater, M. Minagawa, and I. R. Kaplan. Evaluation of isotope ratio (IR) mass spectrometry for the study of drug metabolism. Biomed. Mass Spectrom. 12:502-506 (1985).
T. R. Browne, G. K. Szabo, A. Ajami, and D. G. Browne. Performance of human mass balance studies with stable isotope-labeled drug and continuous flow-isotope ratio mass spectrometry: a progress report. J. Clin. Pharmacol. 38:309-314 (1998).
J. T. Brenna, T. N. Corso, H. J. Tobias, and R. J. Caimi. High-precision continuous-flow isotope ratio mass spectrometry. Mass Spectrom. Rev. 16:227-258 (1997).
F. P. Abramson. CRIMS: Chemical reaction interface mass spectrometry. Mass Spectrom. Rev. 13:341-356 (1994).
F. P. Abramson, Y. Teffera, J. Kusmierz, R. C. Steenwyk, and P. G. Pearson. Replacing 14C with stable isotopes in drug metabolism studies. Drug Metab. Dispos. 24:697-701 (1996).
C. A. Jr. Goldthwaite, F. Y. Hsieh, S. W. Womble, B. J. Nobes, I. A. Blair, L. J. Klunk, and R. F. Mayol. Liquid chromatography/chemical reaction interface mass spectrometry as an alternative to radioisotopes for quantitative drug metabolism studies. Anal. Chem. 68:2996-3001 (1996).
P. Chen, Y. Teffera, G. E. Black, and F. P. Abramson. Flow injection with chemical reaction interface-isotope ratio mass spectrometry: an alternative to off-line combustion for detecting low levels of enriched 13C in mass balance studies. J. Am. Soc. Mass Spectrom. 10:153-158 (1999).
B. L. Osborn and F. P. Abramson. Pharmacokinetic and metabolism studies using uniformly stable isotope labeled proteins with HPLC/CRIMS detection. Biopharm. Drug Dispos. 19:439-444 (1998).
J. R. III Yates. Mass spectrometry and the age of the proteome. J. Mass Spectrom. 33:1-19 (1998).
D. Arnott, K. L. O'Connell, K. L. King, and J. T. Stults. An integrated approach to proteome analysis: Identification of proteins associated with cardiac hypertrophy. Anal. Biochem. 258: 1-18 (1998).
K. Williams. Strategies in proteome research. Electrophoresis 19:NIL3-NIL4 (1998).
N. H. Packer, A. Pawlak, W. C. Kett, A. A. Gooley, J. W. Redmond, and K. L. Williams. Proteome analysis of glycoforms: A review of strategies for the microcharacterisation of glycoproteins separated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 18:452-460 (1997).
B. Kuster and M. Mann. Identifying proteins and post-translational modifications by mass spectrometry. Current Opinions Struct. Biol. 8:393-400 (1998).
J. S. Cottrell. Protein identification by peptide mass fingerprinting. Pept. Res. 7:115-124 (1994).
W. J. Henzel, T. M. Billeci, J. T. Stults, S. C. Wong, C. Grimley, and C. Watanabe. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc. Natl. Acad. Sci. 90:5011-5015 (1993).
M. Mann, P. Hojrup, and P. Roepstorff. Use of mass spectrometric molecular weight information to identify proteins in sequence databases. Biol. Mass Spectrom. 22:338-345 (1993).
J. R. III Yates, S. Speicher, P. R. Griffin, and T. Hunkapiller. Peptide mass maps: a highly informative approach to protein identification. Anal. Biochem. 214:397-408 (1993).
J. K. Eng, A. L. McCormack, and J. R. III Yates. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5:976-989 (1994).
M. Mann and M. Wilm. Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal. Chem. 66:4390-4399 (1994).
K. R. Jonscher and J. R. III Yates. The quadrupole ion trap mass spectrometer—A small solution to a big challenge. Anal. Biochem. 244:1-15 (1997).
B. Spengler. Post-source decay analysis in matrix-assisted laser desorption/ionization mass spectrometry of biomolecules. J. Mass Spectrom. 32:1019-1036 (1997).
M. Wilm and M. Mann. Analytical properties of the nanoelectrospray ion source. Anal. Chem. 68:1-8 (1996).
E. J. Takach, W. M. Hines, D. H. Patterson, P. Juhasz, A. M. Falick, M. L. Vestal, and S. A. Martin. Accurate mass measurements using MALDI-TOF with delayed extraction. J. Protein Chem. 16:363-369 (1997).
K. R. Clauser, P. Baker, and A. L. Burlingame. Role of accurate mass measurement (+/− 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal. Chem. 71:2871-82 (1999).
P. Berndt, U. Hobohm, and H. Langen. Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis 20:3521-3526 (1999).
M. Traini, A. A. Gooley, K. Ou, M. R. Wilkins, L. Tonella, J. C. Sanchez, D. F. Hochstrasser, and K. L. Williams. Towards an automated approach for protein identification in proteome projects. Electrophoresis 19:1941-1949 (1998).
T. I. Stevensen, J. A. Loo, and K. D. Greis. Coupling capillary HPLC to MALDI and N-terminal sequencing of peptides via automated microblotting onto membrane substrates. Anal. Chem. 262:99-109 (1998).
K. L. Walker, R. W. Chiu, C. A. Monnig, and C. L. Wilkins. Off-line coupling of capillary electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Chem. 67:4197-4204 (1995).
H. Orsnes, T. Graf, H. Degn, and K. K. Murray. A rotating ball inlet for on-line MALDI mass spectrometry. Anal. Chem. 72: 251-254 (2000).
Q. Zhan, A. Gusev, and D. M. Hercules. A novel interface for on-line coupling of liquid capillary chromatography with matrix-assisted laser desorption/ionization detection. Rapid Commun. Mass Spectrom. 13:2278-2283 (1999).
P. Cao and M. Moini. Capillary electrophoresis/electrospray ionization high mass accuracy time-of-flight mass spectrometry for protein identification using peptide mapping. Rapid Commun. Mass Spectrom. 12:864-870 (1998).
D. Figeys, S. P. Gygi, Y. Zhang, J. Watts, M. Gu, and R. Aebersold. Electrophoresis combined with novel mass spectrometry techniques: powerful tools for the analysis of proteins and proteomes. Electrophoresis 19:1811-1818 (1998).
H. R. Morris, T. Paxton, M. Panico, R. McDowell, and A. Dell. A novel geometry mass spectrometry, the Q-TOF, for low-femtomole/attomole-range biopolmer sequencing. J. Protein Chem. 16:469-479 (1997).
S. P. Gygi, B. Rist, S. Gerber, F. Turecek, M. H. Gelb, and R. Aerbersold. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotech. 17:994-999 (1999).
A. Apffel, J. Chakel, S. Udiavar, S. Swedberg, W. S. Hancock, C. Souders, and E. Pungor. Applications of new analytical technology to the production of a “well characterized biological”. In F. Brown, A. Lubiniecki, G. Murano (eds.), Characterization of Biotechnology Pharmaceutical Products Dev Biol Stand, vol. 96, Basel, Karger, 1998, pp. 11-25.
G. H. Zhou, G. A. Luo, Y. Zhou, K. Y. Zhou, X. D. Zhang, and L. Q. Huang. Application of capillary electrophoresis, liquid chromatography, electrospray-mass spectrometry and matrix-assisted laser desorption/ionization — time of flight — mass spectrometry to the characterization of recombinant human erythropoietin. Electrophoresis 19:2348-2355 (1998).
S. L. Wu. The use of sequential high-performance liquid chromatography and capillary zone electrophoresis to separate the glycosylated peptides from recombinant tissue plasminogen activator to a detailed level of microheterogeneity. Anal. Biochem. 253:85-97 (1997).
V. Ling, A. W. Guzzetta, E. Canova-Davis, J. T. Stults, W. S. Hancock, T. R. Covey, and B. I. Shushan. Characterization of the tryptic map of recombinant DNA derived tissue plasminogen activator by high-performance liquid chromatography-electrospray ionization mass spectrometry. Anal. Chem. 63: 2909-2915 (1991).
A. Marina, M. A. Garcia, J. P. Albar, J. Yague, J. A. Lopez de Castro, and J. Vazquez. High-sensitivity analysis and sequencing of peptides and proteins by quadrupole ion trap mass spectrometry. J. Mass Spectrom. 34:17-27 (1999).
U. Bahr and M. Karas. Differentiation of “isobaric” peptides and human milk oligosaccharides by exact mass measurements using electrospray ionization orthogonal time-of-flight analysis. Rapid Commun. Mass Spectrom. 13:1052-1058 (1999).
J. Lippincott, E. Hess, and I. Apostol. Mapping of recombinant hemoglobin using immobilized trypsin cartridges. Anal. Biochem. 252:314-325 (1997).
J. W. Bloom, M. S. Madanat, and M. K. Ray. Cell line and site specific comparative analysis of the N-linked oligosaccharides on human ICAM-1des454-532 by electrospray ionization mass spectrometry. Biochem. 35:1856-1864 (1996).
A. Hooker and D. James. The glycosylation heterogeneity of recombinant human IFN-γ. J. Interferon Cytokine Res. 18:287-295 (1998).
J. C. Severs, M. Carnine, H. Eguizabal, and K. K. Mock. Characterization of tyrosine sulfate residues in antihemophilic recombinant factor VIII by liquid chromatography electrospray ionization tandem mass spectrometry and amino acid analysis. Rapid Commun. Mass Spectrom. 13:1016-1023 (1999).
L. A. Merewether, J. Le, M. D. Jones, R. Lee, G. Shimamoto, and H. S. Lu. Development of disulfide peptide mapping and determination of disulfide structure of recombinant human osteoprotegerin chimera produced in Escherichia coli. Arch. Biochem. Biophys. 375:101-110 (2000).
M. Eng, V. Ling, J. A. Briggs, K. Souza, E. Canova-Davis, M. F. Powell, and L. R. De Young. Formulation development and primary degradation pathways for recombinant human nerve growth factor. Anal. Chem. 69:4184-4190 (1997).
R. Senderoff, K. M. Kontor, L. Kreilgaard, J. J. Chang, S. Patell, J. Krakover, J. K. Heffernan, L. B. Snell, and G. B. Rosenberg. Consideration of conformational transition and racemization during process development of recombinant glucagon-like peptide-1. J. Pharm. Sci. 87:183-189 (1998).
C. P. Quan, S. Wu, N. Dasovich, C. Hsu, T. Patapoff, and E. Canova-Davis, Susceptibility of rhDNase I to glycation in the dry-powder state. Anal. Chem. 71:4445-4454 (1999)
E. Watson, B. Shah, R. DePrince, R. W. Hendren, and R. Nelson. Matrix-assisted laser desorption mass spectrometric analysis of a pegylated recombinant protein. Biotechniques 16:278-281 (1994).
R. Mhatre, J. Woodard, and C. Zeng. Strategies for locating disulfide bonds in a monoclonal antibody via mass spectrometry. Rapid Commun. Mass Spectrom. 13:2503-2510 (1999).
R. G. Keck, L. Berleau, R. Harris, and B. A. Keyt. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF. Arch. Biochem. Biophys. 344:103-13 (1997).
J. Wu and J. T. Watson. Optimization of the cleavage reaction for cyanylated cysteinyl proteins for efficient and simplified mass mapping. Anal. Biochem. 258:268-276 (1998).
M. Field, D. Papac, and A. Jones. The use of high-performance anion-exchange chromatography and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry to monitor and identify oligosaccharide degradation. Anal. Biochem. 239: 92-98 (1996).
L. Truong, B. Shyong, E. Chin, J. Herrmann, R. Harris, and V. Ling. Simplified identification of monoclonal antibodies and glycoproteins by mass spectrometry for production control systems. Presentation at the American Society for Mass Spectrometry, Dallas, TX, 1999.
V. Klyuchnicchenko, A. Rodenbrock, J. Thommes, M. Kula, H. Heine, and M. Biselli. Analysis of hybridoma cell culture processes by SDS/gel capillary electrophoresis and matrix-assisted laser desorption ionization-time-of-flight MS. Biotechnol. Appl. Biochem. 27:181-188 (1998).
T. Chan, E. Chin, V. Katta, V. Ling, R. Harris, and J. Herrmann. Peptide mapping by MALDI-TOF-MS of recombinant protein pharmaceuticals as QC lot release test. Poster at the 4th Symposium on the Analysis of Well Characterized Biotechnology Pharmaceuticals, San Francisco, Jan 2000.
K. C. Zoon. Biotechnology Pharmaceuticals 2000. Presented at the 4th Symposium on the Analysis of Well Characterized Biotechnology Pharmaceuticals, San Francisco, Jan 2000.
H. Z. Wan, S. Kaneshiro, J. Frenz, and J. Cacia. Monitoring glycosylation levels of a recombinant antibody using electrospray mass spectrometry with selective ion-monitoring. Anal. Chem. submitted (2000).
B. Austen. Ciphergen's PBS-1 boosts Alzheimer's research. Genetic Eng. News. 20:32-33 (2000).
R. Kniss. Revolution of the drug discovery process using laboratory-on-a-chip technology. Amer. Lab. 30:40-42 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Papac, D.I., Shahrokh, Z. Mass Spectrometry Innovations in Drug Discovery and Development. Pharm Res 18, 131–145 (2001). https://doi.org/10.1023/A:1011049231231
Issue Date:
DOI: https://doi.org/10.1023/A:1011049231231